Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

100.60p
   
  • Change Today:
    -1.20p
  • 52 Week High: 110.00p
  • 52 Week Low: 73.40p
  • Currency: UK Pounds
  • Shares Issued: 536.76m
  • Volume: 279,927
  • Market Cap: £539.98m
  • RiskGrade: 119
  • Beta: 0.27

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
15.94% above the market average15.94% above the market average15.94% above the market average15.94% above the market average15.94% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
1yr Revenue Growth
0.89% below the market average0.89% below the market average0.89% below the market average0.89% below the market average0.89% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
40.03% below the market average40.03% below the market average40.03% below the market average40.03% below the market average40.03% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr DPS Growth
82.04% above the market average82.04% above the market average82.04% above the market average82.04% above the market average82.04% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
5.89% below the market average5.89% below the market average5.89% below the market average5.89% below the market average5.89% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Price Book Ratio
14.72% below the market average14.72% below the market average14.72% below the market average14.72% below the market average14.72% below the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
4.38% above the market average4.38% above the market average4.38% above the market average4.38% above the market average4.38% above the market average
27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average
Price Chg 3m
19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average19.42% below the market average
1.64% above the sector average1.64% above the sector average1.64% above the sector average1.64% above the sector average1.64% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
8.96% above the market average8.96% above the market average8.96% above the market average8.96% above the market average8.96% above the market average
5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average
Momentum 20
2.64% below the market average2.64% below the market average2.64% below the market average2.64% below the market average2.64% below the market average
5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average5.08% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
25.18% above the market average25.18% above the market average25.18% above the market average25.18% above the market average25.18% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
ROCE
51.76% above the market average51.76% above the market average51.76% above the market average51.76% above the market average51.76% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
23.58% above the market average23.58% above the market average23.58% above the market average23.58% above the market average23.58% above the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Forecast EPS
52.2% below the market average52.2% below the market average52.2% below the market average52.2% below the market average52.2% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
38.85% above the market average38.85% above the market average38.85% above the market average38.85% above the market average38.85% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Operating Profit Loss
50.59% above the market average50.59% above the market average50.59% above the market average50.59% above the market average50.59% above the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.22% above the market average35.22% above the market average35.22% above the market average35.22% above the market average35.22% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Cash
35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Buys 1y
56.83% above the market average56.83% above the market average56.83% above the market average56.83% above the market average56.83% above the market average
72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
87.12% above the market average87.12% above the market average87.12% above the market average87.12% above the market average87.12% above the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 100.60p
Change Today -1.20p
% Change -1.18 %
52 Week High 110.00p
52 Week Low 73.40p
Volume 279,927
Shares Issued 536.76m
Market Cap £539.98m
Beta 0.27
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average86.09% below the market average
12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average12.00% above the sector average
Price Trend
59.48% above the market average59.48% above the market average59.48% above the market average59.48% above the market average59.48% above the market average
34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average
Income
47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average47.76% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
12.55% below the market average12.55% below the market average12.55% below the market average12.55% below the market average12.55% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 29-Nov-2021

Time Volume / Share Price
14:44 150 @ 100.63p
14:34 2,592 @ 100.71p
14:33 932 @ 100.49p
14:33 492 @ 100.60p
14:33 612 @ 100.60p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page